Skip to main content
All lobbying filings

Capitoline Consulting, LLC

Capitoline Consulting, LLC filed a Q3 report for Evonik Corporation on October 16, 2025, reporting $50,000 in lobbying income.

Lobbying for Evonik Corporation · Specialty chemicals company

As filed: CAPITOLINE CONSULTING, LLC for EVONIK CORPORATION.

All filings by Capitoline Consulting, LLC · Everything Evonik Corporation has reported

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 16, 2025
Income
$50,000
What the client paid this registrant for the period.
Client based in
New Jersey

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 7

Issues related to TSCA reform Issues related to EPA Premanufacturing Notices Issues related to new chemical reviews PFAS/PFOA oversight and regulatory efforts

Oversight of EPA rules and regulations S.623 / H.R.1415 - No IRIS Act Make American Healthy Again (MAHA) GRAS issue

Issues related to the Administrations tariff actions and related Congressional oversight

FY26 appropriations actions H.R. 4 - Rescissions Act of 2025 - (PL 119-28) H.R. 1 - One Bill Beautiful Bill Act (OBBBA) reconciliation package (PL 119-21)

U.S./China ongoing trade issues Issues related to various trade agreement discussions USMCA Review Process

General issues related to corporate tax S.615/H.R.640 - Chemical Tax Repeal Act H.R. 1 - One Bill Beautiful Bill Act (OBBBA) reconciliation package, Section 899 (PL 119-21)

Issues related to the Surface Transportation Board (STB) and rail mergers

 Bills named in this filing 6

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem